Latest News

Study assesses impact of anti-SARS-CoV-2 convalescent plasma in COVID-19 disease

The current COVID-19 pandemic is still very much active in most parts of the world. In the absence of effective antiviral drugs or vaccines, scientists are studying the use of blood plasma from convalescent COVID-19 patients, banking on its neutralizing antibody content.

Source link

Related posts

X4 Pharmaceuticals Appoints Adam Mostafa as Chief Financial Officer


Coffee Health Effects: Six Cups Could Damage Heart


The changing epidemiological profile of HIV-1 subtype B epidemic in Ukraine


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy